IP Library Granted Patent US 6,858,724
Granted Patent B2
US 6,858,724 · App. 09/925,537 · Granted Feb 22, 2005

Non-mucin type synthetic compounds or its carrier conjugated compounds

Assignee: Kotobuki Pharmaceutical Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,858,724
App. No.
09/925,537
Granted
Feb 22, 2005
Kind
B2
Abstract

The purposes of this invention are preparation of the non-mucin type synthetic compounds-carrier conjugated compounds which are stable against enzymes, and which have the ability of specific reactivity to induce immune response for cancer and HIV. A compound of the general formula (1), wherein A represents OH or sialic acid and/or it's derivatives, and B represents OH or galactose and/or it's derivatives; T represents H or protecting groups of amine; M represents H or OH; X represents oxygen atom, —NH— or S(O)z (where z is 0, 1 or 2); Q is H or oxygen atom; V represents lower alkyl or H; W is straight or branched alkylene groups from 0 to 5; Z is straight or branched alkylene groups from 1 to 5; i, m, and t is 0 or 1; non-mucin type synthetic compounds or it's carrier conjugated compounds, which have above mentioned compounds as a core structure of antigen.

Claims (75)

1. A compound of the general formula (1),

wherein

A represents OH or sialic acid;

B represents OH or galactose;

T represents H or protecting groups of amine;

M represents H or OH;

X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

Q is oxygen atom and can be present or not present;

V represents lower alkyl or H;

W is straight or branched alkylene groups from 0 to 5;

Z is straight or branched alkylene groups from 1 to 5; and

i, m, and t is 0 or 1 with the proviso that i and t cannot be both 0.

2. A compound of the general formula (2),

wherein

A represents OH or sialic acid, and

B represents OH or galactose;

T represents H or protecting groups of amine;

X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

Q is oxygen atom and can be present or not present;

V represents lower alkyl or H;

W is straight or branched alkylene groups from 0 to 5;

Z is straight or branched alkylene groups from 1 to 5;

i, m, and t is 0 or 1 with the proviso that i and t cannot be both 0;

E represents pharmaceutically acceptable carrier compounds;

l is 0 or 1;

F is showed followings,

wherein

J is —CH 2 CH 2 X— or —N(L)-CH 2 CO— where X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

L is H or lower alkyl;

G is H or lower alkyl;

p is 0 to 3; and

y is 0 or 1.

3. A compound of the general formula (3),

wherein

A represents OH or sialic acid, and

B represents OH or galactose;

T represents H or protecting groups of amine;

X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

Q is oxygen atom and can be present or not present;

V represents lower alkyl or H;

W is straight or branched alkylene groups from 0 to 5;

Z is straight or branched alkylene groups from 1 to 5;

i, m, and t is 0 or 1;

E represents pharmaceutically acceptable carrier compounds;

l is 0 or 1; and

r is from 1 to 4.

4. A compound of the general formula (4),

wherein

A represents OH or sialic acid, and

B represents OH or galactose;

T represents H or protecting groups of amine;

X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

Q is oxygen atom and can be present or not present;

V represents lower alkyl or H;

W is straight or branched alkylene groups from 0 to 5;

Z is straight or branched alkylene groups from 1 to 5;

J is —CH 2 CH 2 X— or —N(L)-CH 2 CO— where X represents oxygen atom, —NH— or S(O) z where z is 0, 1 or 2;

i, m, and t is 0 or 1;

p is 0 to 3;

r is from 1 to 4;

U represents H or lower alkyl;

w is 0 to 50; and

y is 1 or 50.

5. The compound thereof of claim 1 , wherein A is sialic acid and B is OH.

6. The compound thereof of claim 2 , wherein A is sialic acid and B is OH.

7. The compound thereof of claim 3 , wherein A is sialic acid and B is OH.

8. The compound thereof of claim 4 , wherein A is sialic acid and B is OH.

9. The compound thereof of claim 1 , wherein A is OH and B is galactose.

10. The compound thereof of claim 2 , wherein A is OH and B is galactose.

11. The compound thereof of claim 3 , wherein A is OH and B is galactose.

12. The compound thereof of claim 4 , wherein A is OH and B is galactose.

13. The compound thereof of claim 1 , wherein both A and B are OH.

14. The compound thereof of claim 2 , wherein both A and B are OH.

15. The compound thereof of claim 3 , wherein both A and B are OH.

16. The compound thereof of claim 4 , wherein both A and B are OH.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 20, 2001
From: TOMIYAMA, HIROSHI; UEYAMA, NAOTO; YANAGIYA, MASAHIRO; OHKURA, YASUFUMI
To: KOTOBUKI PHARMACEUTICAL CO., LTD.
Reel/Frame 012351/0483 →
Priority Claims (1)
JP 2000-244567 · Aug 11, 2000 · national
Continuity (1)
Related Publication 20020107224A1 · Aug 8, 2002